AstraZeneca

AZN | NYSE

Price Alert Chart Builder DCF Calculator

$186.65

+$12.25 (+7.02%)

At close: Oct 30, 2026, 4:00 PM ET

$186.35

-$0.30 (-0.16%)

After-hours: Oct 30, 2026, 7:33 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $289.47B

Enterprise Value $316.71B

Beta 0.21

Average Volume 3.26M

Shares Outstanding (Diluted) 780M

Shares Change YoY 0.06%

Institutional Ownership 52.03%

Exchange NYSE

ISIN GB0009895292

Price Performance

Price Change 1M 15.6%

Price Change 3M 10.0%

Price Change 6M 1.0%

Price Change YTD 6.3%

Price Change 1Y 13.3%

Price Change 3Y 52.0%

Price Change 5Y 49.0%

1M CAGR (ann.) 12.4%

1Y CAGR (ann.) 14.8%

5Y CAGR (ann.) 10.6%

All-Time CAGR 9.9%

Valuation

PE Ratio 14.01

Forward PE 15.28

PEG Ratio 1.19

Forward PEG 2.65

PS Ratio 4.73

Forward PS 4.30

PB Ratio 5.76

P/FCF Ratio 33.12

P/Adj. FCF Ratio 33.12

P/OCF Ratio 21.07

EV/Sales 5.18

EV/EBIT 22.37

EV/EBITDA 15.46

EV/FCF 36.24

Earnings Yield 7.1%

FCF Yield 3.0%

Adj. FCF Yield 3.0%

Financial Health

Net Debt $24.92B

Total Debt $32.2B

Cash & Short-Term Investments $4.96B

Total Assets $115.7B

Current Ratio 0.89

Quick Ratio 0.67

Debt / Equity Ratio 0.64

Debt / EBITDA 1.57

Debt / FCF 3.68

OCF / Debt 0.43

Interest Coverage 7.97

Altman Z-Score 3.53

Piotroski F-Score 7

Margins & Profitability

Gross Profit Margin 79.3%

Operating Profit Margin 22.7%

EBITDA Margin 33.4%

Net Profit Margin 17.0%

FCF Margin 14.3%

Adj. FCF Margin 14.3%

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets 9.0%

Return on Equity 21.7%

Return on Invested Capital 12.7%

Return on Capital Employed 16.4%

Return on Tangible Assets 18.2%

Historical Growth (CAGR)

Revenue CAGR 3Y 11.2%

Revenue CAGR 5Y 15.7%

Revenue CAGR 10Y 9.8%

EPS CAGR 3Y 18.9%

EPS CAGR 5Y 18.3%

EPS CAGR 10Y 14.4%

FCF CAGR 3Y 10.0%

FCF CAGR 5Y 14.5%

FCF CAGR 10Y 20.9%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y 2.6%

Revenue Growth Next 3Y 7.6%

Earnings Date Feb 9, 2027

EPS Estimate (next Q) $2.41

EPS Growth Est (next Q) 13.7%

Revenue Est (next Q) $16.66B

Revenue Growth Est (next Q) 7.4%

Fair Value Estimates

Graham Number $98.91

Graham Upside -47.0%

Lynch Fair Value $244.29

Lynch Upside 30.9%

Price Target $186.67

Price Target Upside 0.0%

Cash Flow

Operating Cash Flow $13.81B

Free Cash Flow $8.74B

Adj. Free Cash Flow $8.74B

FCF Per Share $5.44

OCF Per Share $8.86

OCF/S Ratio 22.4%

Income Statement

Revenue $61.18B

Gross Profit $48.56B

Operating Income $13.88B

EBITDA $20.49B

Net Income $10.42B

EPS (Diluted) $13.32

Revenue / Employee $636.59K

Profit / Employee $108.38K

Employees 96,100

Dividends

Annual Dividend $3.23

Dividend Yield 1.73%

Payout Ratio 24.3%

FCF Payout Ratio 55.9%

Adj. FCF Payout Ratio 55.9%

Dividend Growth (YoY) 2.3%

Pay Frequency Semi-Annual

Ex-Dividend Date Aug 7, 2026